BCACW - （Bison Capital Acquisition Corp.）

Gainers Getty Images Holdings, Inc. (NYSE: GETY ) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB). Brookline Capital Acquisition Corp. (NASDAQ: BCAC ) gained 127.3% to settle at $22.71. AMTD Digital Inc. (NYSE: HKD ) surged 122.4% to settle at $400.25 on continued post-IPO volatility. Senti Biosciences, Inc. (NASDAQ: SNTI ) climbed 68.3% to close at $3.13 after declining 5% on Thursday. NRx Pharmaceuticals, Inc. (NASDAQ: NRXP ) gained 51.6% to close at $0.7930. The U.S. Food and Drug Administration (FDA) recently declined to issue an Emergency Use Authorization (EUA) for NRx Pharmaceuticals’ lead drug ZYESAMI (aviptadil) for subgroup of patients with critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir. Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA ) gained 40.2% to close at $4.74.

Brookline Capital Acquisition Corp. (NASDAQ:BCAC) price on Friday, July 29, rose 125.30% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $22.71. A look at the stock’s price movement, the close in the last trading session was $10.08, moving within a range at $9.94 and $27.74. Turning to … Brookline Capital Acquisition Corp. (BCAC) Price Target And Rating Are Reviewed By Analysts. Read More »

Gainers Getty Images Holdings, Inc. (NYSE: GETY ) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB). Brookline Capital Acquisition Corp. (NASDAQ: BCAC ) gained 127.3% to settle at $22.71. AMTD Digital Inc. (NYSE: HKD ) surged 122.4% to settle at $400.25 on continued post-IPO volatility. Senti Biosciences, Inc. (NASDAQ: SNTI ) climbed 68.3% to close at $3.13 after declining 5% on Thursday. NRx Pharmaceuticals, Inc. (NASDAQ: NRXP ) gained 51.6% to close at $0.7930. The U.S. Food and Drug Administration (FDA) recently declined to issue an Emergency Use Authorization (EUA) for NRx Pharmaceuticals’ lead drug ZYESAMI (aviptadil) for subgroup of patients with critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir. Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA ) gained 40.2% to close at $4.74.

Brookline Capital Acquisition Corp. (NASDAQ:BCAC) price on Friday, July 29, rose 125.30% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $22.71. A look at the stock’s price movement, the close in the last trading session was $10.08, moving within a range at $9.94 and $27.74. Turning to … Brookline Capital Acquisition Corp. (BCAC) Price Target And Rating Are Reviewed By Analysts. Read More »

Wealthspring Capital LLC cut its position in shares of Brookline Capital Acquisition Corp. (NASDAQ:BCACU) by 20.4% in the third quarter, Holdings Channel.com reports. The firm owned 48,000 shares of the companys stock after selling 12,275 shares during the quarter. Wealthspring Capital LLCs holdings in Brookline Capital Acquisition were worth $491,000 at the end of the []

Brookline Capital Acquisition initiated coverage on shares of Procaps Group S.A (NASDAQ:PROC) in a research note published on Tuesday, Stock Target Advisor reports. The brokerage issued a buy rating and a $13.00 target price on the stock. Separately, Brookline Capital Management reissued a buy rating and set a $13.00 price objective on shares of Procaps []

Brookline Capital Acquisition Corp. (NASDAQ:BCAC) was the target of a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 13,400 shares, a growth of 243.6% from the November 15th total of 3,900 shares. Based on an average trading volume of 9,300 shares, the days-to-cover ratio […] The post Brookline Capital Acquisition Corp. (NASDAQ:BCAC) Sees Large Increase in Short Interest appeared first on ETF Daily News .

Brookline Capital Acquisition Corp. (NASDAQ:BCAC) saw a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 3,900 shares, a decline of 90.1% from the October 31st total of 39,500 shares. Based on an average daily trading volume, of 9,800 shares, the short-interest ratio is presently []

Brookline Capital Acquisition Corp. (NASDAQ:BCAC) was the recipient of a significant increase in short interest during the month of October. As of October 29th, there was short interest totalling 39,500 shares, an increase of 1,480.0% from the October 14th total of 2,500 shares. Based on an average daily volume of 9,700 shares, the short-interest ratio []